| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mustard Gas | 14 | 2016 | 35 | 3.440 |
Why?
|
| Lung | 25 | 2014 | 492 | 2.700 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 16 | 2012 | 31 | 2.400 |
Why?
|
| Guinea Pigs | 37 | 2016 | 143 | 1.710 |
Why?
|
| Antioxidants | 8 | 2016 | 443 | 1.540 |
Why?
|
| Lung Injury | 4 | 2016 | 18 | 1.400 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2010 | 69 | 1.090 |
Why?
|
| Receptors, GABA-A | 7 | 2010 | 65 | 1.000 |
Why?
|
| Chemical Warfare Agents | 4 | 2011 | 14 | 0.950 |
Why?
|
| Liposomes | 6 | 2016 | 132 | 0.950 |
Why?
|
| Animals | 53 | 2016 | 16992 | 0.770 |
Why?
|
| Tretinoin | 2 | 2014 | 50 | 0.760 |
Why?
|
| Benzodiazepinones | 9 | 2012 | 21 | 0.710 |
Why?
|
| Acetylcysteine | 3 | 2009 | 57 | 0.680 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2003 | 53 | 0.660 |
Why?
|
| Lung Diseases | 4 | 2006 | 63 | 0.650 |
Why?
|
| Phosphotransferases | 3 | 2014 | 36 | 0.600 |
Why?
|
| Receptors, GABA | 2 | 2012 | 28 | 0.590 |
Why?
|
| Transcription Factor AP-1 | 2 | 2009 | 34 | 0.580 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 5 | 2010 | 29 | 0.550 |
Why?
|
| Soybean Proteins | 2 | 2008 | 38 | 0.520 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 26 | 0.510 |
Why?
|
| Carrier Proteins | 2 | 2010 | 321 | 0.480 |
Why?
|
| Signal Transduction | 3 | 2014 | 2157 | 0.470 |
Why?
|
| Receptors, Adrenergic, beta | 3 | 2009 | 35 | 0.440 |
Why?
|
| Breast Neoplasms | 4 | 2012 | 1723 | 0.440 |
Why?
|
| Retinoids | 1 | 2014 | 25 | 0.440 |
Why?
|
| Erythrocytes | 5 | 2011 | 126 | 0.440 |
Why?
|
| Microsomes | 6 | 2005 | 55 | 0.420 |
Why?
|
| Carcinogens | 4 | 2008 | 126 | 0.390 |
Why?
|
| Models, Biological | 2 | 2014 | 712 | 0.380 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 167 | 0.370 |
Why?
|
| Lactoylglutathione Lyase | 2 | 2002 | 4 | 0.370 |
Why?
|
| Thiolester Hydrolases | 2 | 2002 | 7 | 0.370 |
Why?
|
| Superoxide Dismutase | 7 | 2006 | 158 | 0.370 |
Why?
|
| Male | 31 | 2016 | 23409 | 0.360 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 1019 | 0.360 |
Why?
|
| Blotting, Western | 7 | 2010 | 883 | 0.360 |
Why?
|
| Smoking | 3 | 2007 | 1024 | 0.350 |
Why?
|
| Cell Proliferation | 4 | 2012 | 1455 | 0.350 |
Why?
|
| Liver | 5 | 2002 | 511 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 166 | 0.340 |
Why?
|
| Epithelial Cells | 2 | 2004 | 434 | 0.310 |
Why?
|
| Isoquinolines | 1 | 2010 | 55 | 0.310 |
Why?
|
| Brain Injuries | 1 | 2011 | 129 | 0.310 |
Why?
|
| Antidotes | 1 | 2009 | 2 | 0.310 |
Why?
|
| Phosphatidylcholines | 3 | 2005 | 35 | 0.300 |
Why?
|
| Mitochondria | 6 | 2001 | 523 | 0.300 |
Why?
|
| Pulmonary Alveoli | 3 | 2002 | 28 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 1766 | 0.300 |
Why?
|
| Kidney | 2 | 2002 | 372 | 0.300 |
Why?
|
| Tocopherols | 1 | 2009 | 65 | 0.290 |
Why?
|
| Rats | 11 | 2010 | 3735 | 0.290 |
Why?
|
| Lutein | 1 | 2008 | 6 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 137 | 0.290 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 64 | 0.290 |
Why?
|
| Triiodothyronine | 3 | 2001 | 36 | 0.280 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 458 | 0.250 |
Why?
|
| Brain | 4 | 2011 | 1472 | 0.250 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 561 | 0.250 |
Why?
|
| Anthracenes | 1 | 2006 | 15 | 0.250 |
Why?
|
| Endothelium, Vascular | 2 | 2001 | 263 | 0.250 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 196 | 0.250 |
Why?
|
| Dietary Proteins | 1 | 2006 | 35 | 0.250 |
Why?
|
| Sequence Alignment | 2 | 2003 | 272 | 0.240 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 29 | 0.240 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2005 | 15 | 0.240 |
Why?
|
| Breast | 2 | 2006 | 139 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 139 | 0.230 |
Why?
|
| Transcription Factors | 1 | 2010 | 735 | 0.230 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2010 | 47 | 0.230 |
Why?
|
| Dopamine | 1 | 2007 | 275 | 0.220 |
Why?
|
| Inflammation | 1 | 2010 | 758 | 0.220 |
Why?
|
| Oleic Acids | 2 | 1994 | 11 | 0.210 |
Why?
|
| Anilides | 2 | 1994 | 28 | 0.210 |
Why?
|
| Alopecia | 1 | 2004 | 11 | 0.210 |
Why?
|
| Hair | 1 | 2004 | 38 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2009 | 384 | 0.210 |
Why?
|
| Cadmium | 1 | 2004 | 56 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 291 | 0.200 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 40 | 0.200 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 314 | 0.200 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 77 | 0.190 |
Why?
|
| Vitamin A Deficiency | 2 | 1996 | 13 | 0.190 |
Why?
|
| Phospholipids | 2 | 2002 | 70 | 0.190 |
Why?
|
| Thyronines | 1 | 2002 | 1 | 0.190 |
Why?
|
| Sickle Cell Trait | 2 | 1993 | 19 | 0.190 |
Why?
|
| Diet | 1 | 2008 | 826 | 0.180 |
Why?
|
| Pyrazines | 1 | 2002 | 32 | 0.180 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 64 | 0.180 |
Why?
|
| Calcium | 2 | 2002 | 491 | 0.180 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 3 | 1994 | 5 | 0.180 |
Why?
|
| Smoke | 1 | 2002 | 42 | 0.180 |
Why?
|
| Erythrocyte Membrane | 2 | 1999 | 20 | 0.180 |
Why?
|
| Anticarcinogenic Agents | 1 | 2002 | 77 | 0.180 |
Why?
|
| Antibody Specificity | 1 | 2001 | 76 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1124 | 0.170 |
Why?
|
| Tissue Distribution | 3 | 2011 | 240 | 0.170 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 67 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 135 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2001 | 109 | 0.170 |
Why?
|
| Protein Kinase C | 1 | 2001 | 124 | 0.170 |
Why?
|
| Female | 14 | 2013 | 24698 | 0.160 |
Why?
|
| Base Sequence | 4 | 2005 | 983 | 0.160 |
Why?
|
| Lipid Peroxidation | 4 | 2006 | 140 | 0.160 |
Why?
|
| Drug Carriers | 1 | 2002 | 174 | 0.160 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 5 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 652 | 0.160 |
Why?
|
| Nucleoside-Triphosphatase | 2 | 2012 | 13 | 0.160 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 34 | 0.150 |
Why?
|
| Asthma | 1 | 2003 | 416 | 0.150 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2011 | 59 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2001 | 307 | 0.150 |
Why?
|
| Ceramides | 3 | 2005 | 44 | 0.150 |
Why?
|
| Pulmonary Surfactants | 1 | 1999 | 33 | 0.150 |
Why?
|
| Cyclin D1 | 2 | 2009 | 44 | 0.150 |
Why?
|
| Cholera Toxin | 3 | 2009 | 41 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2009 | 83 | 0.140 |
Why?
|
| Cyclic AMP | 3 | 2009 | 127 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 495 | 0.140 |
Why?
|
| Cholesterol | 2 | 2012 | 232 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2012 | 383 | 0.130 |
Why?
|
| Humans | 14 | 2014 | 43102 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 465 | 0.130 |
Why?
|
| Administration, Inhalation | 2 | 2010 | 92 | 0.130 |
Why?
|
| Obesity | 1 | 2005 | 1151 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2011 | 1003 | 0.130 |
Why?
|
| Microscopy, Electron | 4 | 2005 | 210 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 59 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 749 | 0.120 |
Why?
|
| Exercise | 2 | 1993 | 692 | 0.120 |
Why?
|
| Ligands | 2 | 2008 | 388 | 0.120 |
Why?
|
| Microsomes, Liver | 2 | 2001 | 75 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 508 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2006 | 1271 | 0.120 |
Why?
|
| Adrenal Medulla | 1 | 1994 | 15 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1070 | 0.110 |
Why?
|
| Time Factors | 2 | 2010 | 1857 | 0.110 |
Why?
|
| Blood Proteins | 2 | 2009 | 77 | 0.110 |
Why?
|
| Vitamin A | 1 | 1995 | 86 | 0.110 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 66 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 1542 | 0.110 |
Why?
|
| Linoleic Acids | 1 | 1994 | 3 | 0.110 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 7 | 0.100 |
Why?
|
| Hyperpigmentation | 1 | 2013 | 10 | 0.100 |
Why?
|
| Dihydroalprenolol | 2 | 2009 | 6 | 0.100 |
Why?
|
| Free Radicals | 3 | 2003 | 70 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 1993 | 35 | 0.100 |
Why?
|
| Tritium | 2 | 2008 | 46 | 0.100 |
Why?
|
| Kinetics | 3 | 2007 | 695 | 0.100 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2003 | 9 | 0.100 |
Why?
|
| Cell Line | 3 | 2004 | 1410 | 0.100 |
Why?
|
| Body Weight | 3 | 2005 | 429 | 0.100 |
Why?
|
| Annexins | 1 | 1992 | 6 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2003 | 54 | 0.100 |
Why?
|
| Caspases | 2 | 2003 | 148 | 0.090 |
Why?
|
| GABA Agonists | 1 | 2012 | 21 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 1992 | 12 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 190 | 0.090 |
Why?
|
| Trachea | 1 | 2011 | 25 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2003 | 168 | 0.090 |
Why?
|
| Permeability | 1 | 2011 | 67 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 86 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 1993 | 172 | 0.090 |
Why?
|
| alpha-Synuclein | 1 | 2011 | 61 | 0.090 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2010 | 3 | 0.090 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2010 | 22 | 0.080 |
Why?
|
| Submandibular Gland | 1 | 1990 | 3 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 719 | 0.080 |
Why?
|
| Neoplasms | 1 | 2002 | 1377 | 0.080 |
Why?
|
| Aging | 2 | 1993 | 783 | 0.080 |
Why?
|
| Aerosols | 1 | 2010 | 54 | 0.080 |
Why?
|
| Isoproterenol | 2 | 2001 | 39 | 0.080 |
Why?
|
| Pregnancy, Animal | 1 | 1990 | 14 | 0.080 |
Why?
|
| Oxygen | 1 | 1992 | 218 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1180 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 1990 | 15 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 151 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2010 | 27 | 0.080 |
Why?
|
| Glutathione Peroxidase | 4 | 2006 | 112 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 34 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2003 | 358 | 0.080 |
Why?
|
| Submitochondrial Particles | 1 | 1989 | 5 | 0.080 |
Why?
|
| Catalase | 4 | 2006 | 110 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 75 | 0.080 |
Why?
|
| Meclofenoxate | 1 | 1989 | 2 | 0.080 |
Why?
|
| Glycolates | 1 | 1989 | 6 | 0.080 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2009 | 5 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 32 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1989 | 23 | 0.080 |
Why?
|
| Activating Transcription Factors | 1 | 2009 | 5 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 28 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2010 | 165 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 26 | 0.070 |
Why?
|
| Membranes | 1 | 2009 | 18 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 183 | 0.070 |
Why?
|
| Apoptosis | 2 | 2010 | 1568 | 0.070 |
Why?
|
| Intracellular Space | 1 | 2009 | 37 | 0.070 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2008 | 4 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 701 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 290 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2010 | 346 | 0.070 |
Why?
|
| Cell Division | 2 | 2002 | 311 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 55 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2005 | 462 | 0.070 |
Why?
|
| Polymyxins | 1 | 1987 | 1 | 0.070 |
Why?
|
| Polymyxin B | 1 | 1987 | 8 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2010 | 760 | 0.070 |
Why?
|
| Dactinomycin | 2 | 2002 | 11 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 164 | 0.070 |
Why?
|
| Acyltransferases | 1 | 1987 | 22 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2002 | 30 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1596 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1999 | 27 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 2676 | 0.070 |
Why?
|
| Food | 1 | 2008 | 103 | 0.070 |
Why?
|
| Motor Activity | 2 | 2007 | 437 | 0.060 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2007 | 27 | 0.060 |
Why?
|
| Phenotype | 1 | 2010 | 780 | 0.060 |
Why?
|
| Cattle | 2 | 2001 | 498 | 0.060 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2007 | 46 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 457 | 0.060 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2006 | 38 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2009 | 986 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 83 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 655 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 204 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2006 | 128 | 0.060 |
Why?
|
| DNA | 1 | 2008 | 592 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 374 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.060 |
Why?
|
| Protein Binding | 1 | 2008 | 1082 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 294 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2003 | 35 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 46 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2006 | 201 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2004 | 91 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2003 | 52 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 456 | 0.050 |
Why?
|
| Risk Factors | 1 | 2012 | 3994 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 286 | 0.050 |
Why?
|
| Erythrocyte Count | 2 | 1993 | 11 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2003 | 23 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 88 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 70 | 0.050 |
Why?
|
| RNA Probes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Thiones | 1 | 2002 | 5 | 0.050 |
Why?
|
| Enzyme Induction | 1 | 2002 | 52 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 518 | 0.050 |
Why?
|
| Annexin A1 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Pyruvaldehyde | 1 | 2002 | 2 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2002 | 48 | 0.050 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 2 | 1993 | 10 | 0.050 |
Why?
|
| Thiophenes | 1 | 2002 | 32 | 0.050 |
Why?
|
| NADP | 2 | 1993 | 37 | 0.040 |
Why?
|
| Serotonin | 1 | 2001 | 123 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 126 | 0.040 |
Why?
|
| Cell Survival | 1 | 2004 | 945 | 0.040 |
Why?
|
| Aorta | 1 | 2001 | 198 | 0.040 |
Why?
|
| Pregnancy | 3 | 1991 | 1772 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 132 | 0.040 |
Why?
|
| Protein Transport | 1 | 2001 | 296 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 1990 | 77 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 199 | 0.040 |
Why?
|
| Lipids | 1 | 2002 | 256 | 0.040 |
Why?
|
| Epinephrine | 1 | 1999 | 36 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 18 | 0.040 |
Why?
|
| Densitometry | 1 | 1999 | 16 | 0.040 |
Why?
|
| Water | 1 | 2002 | 316 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 968 | 0.040 |
Why?
|
| Cell Membrane | 2 | 1994 | 403 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 592 | 0.040 |
Why?
|
| Lasers | 1 | 1999 | 57 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 197 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1997 | 21 | 0.030 |
Why?
|
| Gene Library | 1 | 1997 | 62 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 196 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2001 | 1621 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1996 | 65 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 455 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 515 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1999 | 561 | 0.030 |
Why?
|
| Atenolol | 1 | 1994 | 4 | 0.030 |
Why?
|
| Propanolamines | 1 | 1994 | 13 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 109 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 54 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 1994 | 20 | 0.030 |
Why?
|
| Brassica | 1 | 1994 | 16 | 0.030 |
Why?
|
| Plant Oils | 1 | 1994 | 20 | 0.030 |
Why?
|
| Dermatitis | 1 | 2013 | 10 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 1993 | 2 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 63 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 59 | 0.030 |
Why?
|
| Cotinine | 1 | 1993 | 44 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 1993 | 4 | 0.030 |
Why?
|
| Melanins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Choline | 1 | 1993 | 61 | 0.020 |
Why?
|
| Hemolysis | 1 | 1993 | 60 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 140 | 0.020 |
Why?
|
| Cytosol | 1 | 1992 | 97 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 148 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1992 | 13 | 0.020 |
Why?
|
| Hematocrit | 1 | 1992 | 26 | 0.020 |
Why?
|
| Adult | 3 | 2013 | 13872 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1992 | 69 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1992 | 113 | 0.020 |
Why?
|
| Diglycerides | 1 | 1991 | 9 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 458 | 0.020 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 1990 | 2 | 0.020 |
Why?
|
| Fetus | 1 | 1991 | 101 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 219 | 0.020 |
Why?
|
| NAD | 1 | 1990 | 45 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1081 | 0.020 |
Why?
|
| Convulsants | 1 | 1989 | 5 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1989 | 36 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 44 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1990 | 108 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 616 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 1988 | 90 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 57 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1988 | 98 | 0.020 |
Why?
|
| Glutathione | 1 | 1988 | 171 | 0.020 |
Why?
|
| Reducing Agents | 1 | 2006 | 13 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2006 | 25 | 0.020 |
Why?
|
| Enzymes | 1 | 2006 | 35 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 258 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 108 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 155 | 0.010 |
Why?
|
| Binding Sites | 1 | 1987 | 671 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 277 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 5080 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 6081 | 0.010 |
Why?
|